Related content

Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome

By Chim C.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 181-182

Springer Publishing Company

Access to resources Recommend Favorite

Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report

By        

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3064-3066

Spandidos Publications

Access to resources Recommend Favorite

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

By Held Lauren A.   Rizzieri David   Long Gwynn D.   Gockerman Jon P.   Diehl Louis F.   Castro Carlos M. de   Moore Joseph O.   Horwitz Mitchell E.   Chao Nelson J.   Gasparetto Cristina  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 172-176

Informa Healthcare

Access to resources Recommend Favorite

Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

By Szturz Petr  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1324-1326

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib-induced acute pancreatitis in a patient with multiple myeloma

By Wang He-Hua   Tsui James   Wang Xiao-Yan   Liu Shou-Sheng   Li Juan  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1404-1405

Informa Healthcare

Access to resources Recommend Favorite